Basem William MD MRCP(UK), FACP

Hematologic Oncology

Hematologist/Oncologist, OhioHealth

500 Thomas LnSuite A3Columbus, OH 43214
Phone+1 614-566-2500
Fax+1 614-533-0335

Dr. William is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. William's full profile Already have an account?

Summary

Dr. Basem William is an oncology specialist based in Columbus, OH, with a subspecialty in hematologic oncology. He completed his fellowship in Hematology and Medical Oncology at the University of Nebraska Medical Center College of Medicine from 2009 to 2012, following his medical education at Ain Shams University and residency in Internal Medicine at UPMC Medical Education. Currently, he serves as the Clinical Director of the BMT program at Bing Cancer Center and has held various academic positions, including Associate Professor roles at Ohio State University Wexner Medical Center and The OSUCCC - James. His expertise includes hematologic oncology and hematopoietic stem cell transplantation, and he has contributed to numerous clinical trials. Dr. William has an extensive publication record, with research topics ranging from Hodgkin's lymphoma to racial disparities in cancer survival. He has received several certifications, including from the American College of Physicians and CMS Meaningful Use, and holds an MRCP(UK) membership since 2005.

Education & Training

The MetroHealth System/Case Western Reserve UniversityResidency, Gastroenterology, 2021 - 2027
University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
UPMC Medical EducationResidency, Internal Medicine, 2002 - 2005
Ain Shams University Faculty of MedicineClass of 1996

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OH State Medical License 2012 - 2027
CA State Medical License 2007 - 2023
IN State Medical License 2008 - 2013
NE State Medical License 2008 - 2012
NY State Medical License 2008 - 2010
VA State Medical License 2007 - 2010
MD State Medical License 2007 - 2009
ME State Medical License Active through 2009
DC State Medical License 2007 - 2008
PA State Medical License 2002 - 2005
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology
Join now to see all

Awards, Honors, & Recognition

Fellow American College of Physicians, 2015
CMS Meaningful Use Stage 1 Certification Rhapsody Connect, Orion Health, 2015
CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2015

Clinical Trials

Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma Start of enrollment: 2009 Nov 12
COMPLETED
PHASE1, PHASE2
Double Cord Versus Haploidentical (BMT CTN 1101)
COMPLETED
PHASE3
Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
TERMINATED
PHASE2

Publications & Presentations

PubMed

Post-treatment circulating tumor DNA in large B-cell lymphoma with an immunoglobulin-based assay: real-world outcomes.
Patrick Gould, Devyn Coskey, Xin Ma, Shikun Wang, Sonia Godbole
Haematologica. 2026-08-13
ctDNA for MRD assessment is prognostic and predictive in newly diagnosed and relapsed/refractory lymphoma.
Natalie Galanina, Madiha Iqbal, Sarah Tomassetti, Darryl Nousome, Antony Tin
Blood Neoplasia. 2026-08-01
Phase I Trial of Venetoclax and BEAM Followed by Autologous Stem Cell Transplant for High-Risk Non-Hodgkin Lymphoma.
Joseph E Maakaron, Qiuhong Zhao, Jayalakshmi P Balakrishna, Marcin Puto, Sam Penza
Transplantation and Cellular Therapy. 2026-07-01

Journal Articles

IPH4102 in relapsed/refractory Cutaneous T Cell Lymphoma (CTCL): Results of the First-in-Human Multicenter Phase 1 Study
Pierluigi Porcu, Basem William, Michael Khodadoust, European Journal of Cancer

Abstracts/Posters

Blinatumomab/Lenalidomide in Relapsed/Refractory Non-HodgkinÍs Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative Analysis
Basem M. William, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malig...
Basem M. William, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Bnz-1, a Selective _-Chain Cytokine Inhibitor Has Clinical Activity in Patients with Cutaneous T Cell Lymphoma By Selectively Blocking IL-2, IL-15 and IL-9 Signaling: ...
Basem M. William, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018